Investor Relations

About Us

PAVmed is a medical device company employing a business model to bring innovative products from concept to commercialization with speed and capital efficiency, while enhancing and accelerating value creation.

PAVmed is building a deep pipeline of products encompassing a broad spectrum of clinical areas possessing attractive regulatory pathways and market opportunities currently exceeding $4 billion.  The company currently has five lead products to provide multiple near-term value creation opportunities

The Company is led by a team of accomplished medical device entrepreneurs. The leadership team has previously successfully implemented its unique business model of creating value with modest capital investment in four single-product companies, each of which rapidly advanced towards commercialization. Two of these four products have been cleared and commercialized, while two products are currently undergoing FDA review. PAVmed leverages this unique business model.

By establishing a long-term multi-product company with access to public capital, the company plans to build an expanding pipeline of innovative products across a range of specialties and clinical conditions.

Featured Press Releases

  • 4/10/17 4:52 pm EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it filed a registration statement on Form S-4 with the Securities and Exchange Commission relating to the Company’s previously announced intention to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common Stock will become exchangeable for units (the “New Units”). Pursuant to the Exchange, eachmore...
  • 3/31/17 9:00 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq:PAVM)(Nasdaq:PAVMW), a highly differentiated, multi-product medical device company, today announced a revised time for the Company’s presentation at the 16th Annual Needham Healthcare Conference. Lishan Aklog, M.D., chief executive officer will provide a corporate overview, discuss the Company’s innovative business model and review PAVmed’s lead products on Tuesday, April 4, 2017 at 12:50 p.m. Eastern Time. The conference ismore...
  • 3/28/17 7:30 am EDT
    NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer, will present at the 16th Annual Needham Healthcare Conference on Wednesday, April 5, 2017, at 10:20 a.m. Eastern time. Dr. Aklog will provide a corporate overview, discuss the company’s innovative business model and review PAVmed’s lead products. The conferencemore...

In the News

  • Forbes
    11/7/16 5:13 pm EST

    Shares of small-capitalization companies have been busy beavers, besting larger-cap stocks since February after a long period of under-performance, with the Russell 2000 outscoring the S&P 500-stock index. And analysts point out that small-cap investing has proven to be the better play for the long term.

SEC Filings

Click Here to view PAVMed's SEC filings

INVESTOR PRESENTATION

Click Here to view PAVmed’s current Investor Presentation